Biotech announced that the company recently received the “Drug Registration Certificate” for scuchiumab injections approved and issued by the State Drug Administration. The drug approval numbers are Sinopharm Standard S20260076 and Sinopharm Standard S20260077. Indications include psoriasis, ankylosing spondylitis, and psoriatic arthritis.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.